```html

Ogilvie’s Syndrome – A Comprehensive Medical Guide

Overview

Ogilvie’s syndrome, also called acute colonic pseudo‑obstruction, is a rapid dilatation of the colon without a mechanical blockage. It mimics a true bowel obstruction but results from an imbalance in the autonomic regulation of colonic motility.

The condition most often affects hospitalized patients, particularly those who are critically ill, have undergone major surgery, or are receiving certain medications. It can occur at any age, but the median age of onset is around 60 years, and men are slightly more frequently affected than women (Mayo Clinic).

Although exact prevalence is difficult to determine, pseudo‑obstruction accounts for roughly 3 % of all cases of acute colonic obstruction in hospitalized patients (Cleveland Clinic). Recognizing it early is crucial because the colon can perforate if the dilation exceeds 10–12 cm, leading to a mortality rate of up to 30 % in severe cases (NIH – Gut).

Symptoms

The clinical picture ranges from mild abdominal discomfort to life‑threatening distension. Common symptoms include:

• Abdominal distension – Often the first sign; the abdomen can become markedly swollen and tense.
• Abdominal pain or cramping – Typically diffuse and less severe than pain from mechanical obstruction.
• Nausea and vomiting – May be bilious or contain small amounts of fecal material.
• Constipation or obstipation – Absence of flatus or stool for >24 hours.
• Loss of appetite
• Low‑grade fever – May occur if inflammation or early infection develops.
• Earliest bowel sounds – Can be hyperactive initially, then become hypoactive or absent.

In advanced cases, patients may develop:

• Severe tenderness, guarding, or rebound tenderness (suggesting perforation).
• Signs of sepsis: rapid heart rate, low blood pressure, confusion.

Causes and Risk Factors

Ogilvie’s syndrome is primarily a functional disorder. The exact pathophysiology is not fully understood, but it is believed to involve:

• Autonomic imbalance – Excess sympathetic tone or reduced parasympathetic (vagal) stimulation leads to colonic atony.
• Electrical conduction abnormalities – Disruption of the myenteric plexus activity.

Risk factors that tip the balance toward colonic paralysis include:

Medical and Surgical Factors

• Recent major abdominal or pelvic surgery, especially colorectal, obstetric, or vascular procedures.
• Trauma, especially spinal cord injury.
• Severe infection or sepsis (e.g., pneumonia, urinary tract infection).
• Electrolyte disturbances – especially hypokalemia, hypomagnesemia, or hypercalcemia.
• Critical illness requiring intensive care unit (ICU) admission.
• Prolonged immobilization or bed rest.

Medications

• Opioids (morphine, fentanyl) – reduce colonic motility.
• Anticholinergics (e.g., atropine, scopolamine).
• Calcium channel blockers.
• Neuroleptics and certain antidepressants.

Other Conditions

• Metabolic disorders such as diabetes mellitus.
• Neurologic diseases – Parkinson’s disease, multiple sclerosis.
• Severe hypothyroidism.

Diagnosis

Diagnosing Ogilvie’s syndrome requires a high index of suspicion because its signs overlap with true mechanical obstruction. The work‑up follows a stepwise approach:

Clinical Evaluation

• Detailed history focusing on recent surgeries, medications, and comorbidities.
• Physical exam looking for massive abdominal distension, tympany on percussion, and evaluation of bowel sounds.

Imaging Studies

• Abdominal X‑ray (plain film) – First‑line; shows colonic dilation, usually affecting the cecum and right colon. A diameter >10 cm is worrisome for perforation risk.
• CT abdomen & pelvis with contrast – Gold standard to exclude a true mechanical obstruction, neoplasm, or volvulus. CT also identifies signs of ischemia or perforation.
• Ultrasound – Helpful in ICU settings where radiation exposure is a concern; can demonstrate fluid‑filled, dilated loops.

Laboratory Tests

• Complete blood count – look for leukocytosis.
• Electrolytes – correct hypokalemia, hypomagnesemia.
• Serum lactate – elevated levels suggest ischemia.
• Inflammatory markers (CRP, ESR) – may rise if perforation or infection develops.

Exclusion of Mechanical Causes

Colonoscopy or contrast enema is occasionally performed if imaging is equivocal, but these procedures carry a perforation risk in a severely dilated colon and should be done cautiously.

Treatment Options

Management is aimed at decompressing the colon, correcting underlying precipitating factors, and preventing perforation. Treatment can be divided into conservative, pharmacologic, and interventional approaches.

Conservative Measures (First 24‑48 h)

• Nasogastric and/or rectal tube – Decompresses the gastrointestinal tract.
• Fluid and electrolyte replacement – Correct hypokalemia, hypomagnesemia, and acid‑base disturbances.
• Discontinue offending medications – Stop opioids, anticholinergics, or calcium channel blockers when possible.
• Mobilization – Early ambulation, if medically feasible, stimulates bowel motility.
• Position changes – Prone or left lateral decubitus positioning can aid gas evacuation.

Pharmacologic Therapy

• Neostigmine – An acetylcholinesterase inhibitor; given intravenously (2 mg over 3–5 min) with cardiac monitoring. A response (passage of flatus/stool) occurs in ~80 % of cases within 30 min (CDC guidelines). Contraindications include bradycardia, recent myocardial infarction, or active asthma.
• Prokinetic agents – Limited evidence; agents like metoclopramide are sometimes used but are less effective than neostigmine.

Endoscopic Decompression

If there is no response to neostigmine within 24 h or if the colon is >12 cm, colonoscopic decompression is recommended. A flexible sigmoidoscope or colonoscope is advanced to relieve the pressure, often with a decompression tube left in place for 24‑48 h.

Surgical Intervention

Surgery is reserved for:

• Perforation or signs of peritonitis.
• Failure of both medical and endoscopic measures after 48–72 h.
• Colonic ischemia identified on imaging.

Procedures range from percutaneous cecostomy tube placement to segmental colectomy, depending on the severity.

Supportive Care

• Broad‑spectrum antibiotics if perforation is suspected.
• Analgesia with non‑opioid agents (acetaminophen, NSAIDs) to avoid further motility reduction.
• Close monitoring of abdominal girth, vital signs, and serial abdominal films.

Living with Ogilvie’s Syndrome

After acute management, many patients face recurrent episodes, especially if the underlying risk factors persist. Practical tips for daily life include:

• Medication review – Work with your physician or pharmacist to avoid or minimize opioid and anticholinergic use.
• Hydration – Aim for 2–3 L of fluid per day (unless contraindicated) to keep stool soft.
• Dietary fiber – Gradually increase soluble fiber (e.g., oatmeal, psyllium) while monitoring tolerance.
• Regular bowel routine – Set a consistent time each day for attempting bowel movements; a warm shower or abdominal massage can stimulate peristalsis.
• Physical activity – Even gentle walking for 10–15 minutes 2–3 times daily improves colonic transit.
• Electrolyte vigilance – Periodic lab checks if you have chronic kidney disease, diuretic use, or vomiting.
• Prompt reporting – Contact your care team right away if you notice increasing abdominal girth, new pain, or inability to pass gas.

Prevention

Because many triggers are iatrogenic, prevention focuses on careful medical management:

• Optimized pain control – Use multimodal analgesia (acetaminophen, regional blocks) to spare opioids.
• Medication stewardship – Review all prescribed drugs for anticholinergic burden, especially in the elderly.
• Early mobilization protocols – Implement physical therapy within 24 h after surgery when feasible.
• Electrolyte monitoring – Replace potassium and magnesium promptly in postoperative or ICU patients.
• Prophylactic neostigmine – In high‑risk patients with persistent colon dilation >8 cm, some centers give a low‑dose neostigmine infusion under monitoring.

Complications

If left untreated, Ogilvie’s syndrome can lead to serious outcomes:

• Colonic perforation – The most feared complication; risk rises sharply when cecal diameter exceeds 10–12 cm.
• Sepsis and peritonitis – Result from bacterial translocation after perforation.
• Ischemic colitis – Prolonged pressure compromises blood flow.
• Chronic bowel dysfunction – Recurrent pseudo‑obstruction may cause long‑term motility issues.
• Increased mortality – Reported up to 30 % in patients who develop perforation; overall mortality for all cases is 10–15 % (NIH – Gut 2017).

When to Seek Emergency Care

---

References:
1. Mayo Clinic. Ogilvie’s syndrome (acute colonic pseudo‑obstruction). https://www.mayoclinic.org
2. Cleveland Clinic. Acute colonic pseudo‑obstruction. https://my.clevelandclinic.org
3. NIH. “Outcomes of acute colonic pseudo‑obstruction: a systematic review.” *Gut* 2017;66:904‑913. PMC5661249
4. CDC. Guidelines for the prevention of postoperative complications. https://www.cdc.gov
5. WHO. Surgical site infection prevention. https://www.who.int

```